2004
DOI: 10.1016/j.bpa.2003.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and laboratory diagnosis of acute renal failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(12 citation statements)
references
References 80 publications
0
11
0
1
Order By: Relevance
“…A decreased diuresis, particularly in critically ill patients, might be one of the first signs that draw attention to a decreased renal function. However, this criterion does not exclude prerenal factors, and most cases of AKI that are encountered in contemporary clinical practice are nonoliguric in nature (31). In addition, urine output is influenced by the eventual administration of diuretics.…”
Section: Defining Patients At Risk For Acute Renal Injurymentioning
confidence: 99%
“…A decreased diuresis, particularly in critically ill patients, might be one of the first signs that draw attention to a decreased renal function. However, this criterion does not exclude prerenal factors, and most cases of AKI that are encountered in contemporary clinical practice are nonoliguric in nature (31). In addition, urine output is influenced by the eventual administration of diuretics.…”
Section: Defining Patients At Risk For Acute Renal Injurymentioning
confidence: 99%
“…icroscopic examination of the urine sediment plays an important role in the evaluation of patients with kidney injury (1)(2)(3)(4)(5). Although many nephrologists evaluate the urine sediment themselves, some practitioners have delegated urine sediment interpretation to their local clinical laboratory for interpretation by trained technologists (1).…”
mentioning
confidence: 99%
“…6 Therefore, noninvasive early biomarkers that predict subclinical renal damage are necessary. The most promising biomarkers are human kidney injury molecule-1 (KIM-1), liver-type fatty-acid binding protein (L-FABP), N-acetyl-b-D-glucosaminidase A (NAG), and neutrophil gelatinase-associated lipocalin (NGAL).…”
Section: Introductionmentioning
confidence: 99%